Immunitybio IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 7.45 USD | 12,43 USD | 1,95 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 12,75 USD | 3 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 1.047.353.977 | 34,6 | 10,23 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Immunitybio Inc
Mitarbeiter 684
Handelsplatz NASDAQ
Ticker Symbol IBRX
IPO Datum 2015-07-28
Adresse 3530 John Hopkins Court, San Diego, CA, United States, 92121
Webseite https://immunitybio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc. | Founder, Executive Chairman and Global Chief Scientific & Medical Officer |
| 2 | Mr. Richard Gerald Adcock | President, CEO & Director |
| 3 | Mr. David C. Sachs | Chief Financial Officer |
| 4 | Ms. Regan J. Lauer | Chief Accounting Officer |
| 5 | Dr. Barry J. Simon M.D. | Chief Corporate Affairs Officer & Director |
| 6 | Dr. Enrique Diloné Ph.D., RAC | Chief Technology Officer |
| 7 | Ms. Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy |
| 8 | Ms. Emily Arison | Senior Vice President of Human Resources |
| 9 | Dr. Leonard S. Sender M.D. | Chief Medical Officer of Liquid Tumors & Cell Therapy |
| 10 | Dr. Sandeep K. Reddy M.D. | Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 7 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 9 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 10 | HRT FINANCIAL LLC | 0,00% | 0,00 Mio. USD |
| 11 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 12 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 13 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 14 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 16 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 17 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 18 | SEB Asset Management AB | 0,00% | 0,00 Mio. USD |
| 19 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |
| 20 | Barclays PLC | 0,00% | 0,00 Mio. USD |